Published in New Biol on November 01, 1990
Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production. J Virol (1994) 4.40
The C terminus of human immunodeficiency virus type 1 matrix protein is involved in early steps of the virus life cycle. J Virol (1992) 2.51
The role of Gag in human immunodeficiency virus type 1 virion morphogenesis and early steps of the viral life cycle. J Virol (1996) 2.31
Phenotypic characterization of insertion mutants of the human immunodeficiency virus type 1 Gag precursor expressed in recombinant baculovirus-infected cells. J Virol (1994) 1.99
Human immunodeficiency virus type 1 MA deletion mutants expressed in baculovirus-infected cells: cis and trans effects on the Gag precursor assembly pathway. J Virol (1995) 1.24
The human immunodeficiency virus (HIV) gag gene product p18 is responsible for enhanced fusogenicity and host range tropism of the highly cytopathic HIV-1-NDK strain. J Virol (1992) 0.88
Inhibition of early and late events of the HIV-1 replication cycle by cytoplasmic Fab intrabodies against the matrix protein, p17. Mol Med (1997) 0.86
Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies. Lupus (2000) 2.81
Letter: New enterovirus type associated with epidemic of aseptic meningitis and-or hand, foot, and mouth disease. Lancet (1974) 2.16
The site of an immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 does not constitute the neutralization epitope. J Virol (1990) 1.76
Hemolysis-in-gel and neutralization tests for determination of antibodies to mumps virus. J Clin Microbiol (1976) 1.63
Epidemic acute diarrhoea in adults associated with infantile gastroenteritis virus. Lancet (1978) 1.55
Presence of antibodies to a putatively immunosuppressive part of human immunodeficiency virus (HIV) envelope glycoprotein gp41 is strongly associated with health among HIV-positive subjects. Proc Natl Acad Sci U S A (1988) 1.55
O-glycosidic carbohydrate-peptide linkages of Herpes simplex virus glycoproteins. Arch Virol (1981) 1.53
Blood donor sera with false-positive Western blot reactions to human immunodeficiency virus. Lancet (1986) 1.53
Human immunodeficiency virus type 1 biological variation and coreceptor use: from concept to clinical significance. J Intern Med (2011) 1.44
Specificity of Fc receptors induced by herpes simplex virus type 1: comparison of immunoglobulin G from different animal species. J Virol (1985) 1.39
Etiology of community-acquired pneumonia in patients requiring hospitalization. Eur J Clin Microbiol (1985) 1.39
Expression of human endogenous retroviral sequences in peripheral blood mononuclear cells of healthy individuals. J Gen Virol (1992) 1.33
Diversity of human endogenous retrovirus class II-like sequences. J Gen Virol (1999) 1.32
Evolution of human endogenous retroviral sequences: a conceptual account. Cell Mol Life Sci (2008) 1.26
Repetitive elements in the 5' untranslated region of a human zinc-finger gene modulate transcription and translation efficiency. Genomics (2001) 1.23
Identification of novel porcine endogenous betaretrovirus sequences in miniature swine. J Virol (2001) 1.18
Usefulness of real-time PCR for lytA, ply, and Spn9802 on plasma samples for the diagnosis of pneumococcal pneumonia. Clin Microbiol Infect (2009) 1.17
Differences in mechanisms of transformation by independent feline sarcoma virus isolates. J Virol (1981) 1.16
Viral antibody screening system that uses a standardized single dilution immunoglobulin G enzyme immunoassay with multiple antigens. J Clin Microbiol (1983) 1.15
Screening for human T cell leukaemia/lymphoma virus among blood donors in Sweden: cost effectiveness analysis. BMJ (1998) 1.12
Snyder-Theilen feline sarcoma virus P85 contains a single phosphotyrosine acceptor site recognized by its associated protein kinase. J Virol (1981) 1.11
Abelson murine leukaemia virus transformation involves loss of epidermal growth factor-binding sites. Nature (1980) 1.05
Search for DNA of exogenous mouse mammary tumor virus-related virus in human breast cancer samples. J Gen Virol (2007) 1.00
Structure and genomic organization of a novel human endogenous retrovirus family: HERV-K (HML-6). J Gen Virol (1997) 0.99
Varieties of long-term outcome among patients in psychoanalysis and long-term psychotherapy. A review of findings in the Stockholm Outcome of Psychoanalysis and Psychotherapy Project (STOPP). Int J Psychoanal (2000) 0.98
Gene expression profiling of human placentas from preeclamptic and normotensive pregnancies. Mol Hum Reprod (2006) 0.97
Antibodies to a putative HIV gp41 immunosuppressive peptide, pHIVIS (583-599), do not correlate significantly with outcome in HIV infection. AIDS (1990) 0.97
Is quantitative PCR for the pneumolysin (ply) gene useful for detection of pneumococcal lower respiratory tract infection? Clin Microbiol Infect (2009) 0.97
Involvement of a high-molecular-weight polyprotein translational product of Snyder-Theilen Feline sarcoma virus in malignant transformation. J Virol (1981) 0.97
Patterns of antibodies to human immunodeficiency virus proteins in different subclasses of IgG. J Infect Dis (1987) 0.96
Stillbirths and intrauterine infection, histologic chorioamnionitis and microbiological findings. Int J Gynaecol Obstet (1996) 0.96
Spliced human endogenous retroviral HERV-H env transcripts in T-cell leukaemia cell lines and normal leukocytes: alternative splicing pattern of HERV-H transcripts. J Gen Virol (1997) 0.96
Isolation of a human endogenous retroviral HERV-H element with an open env reading frame. Virology (1999) 0.96
SYBR Green real-time reverse transcription-polymerase chain reaction assay for the generic detection of coronaviruses. Arch Virol (2006) 0.95
Differential expression of human endogenous retroviral sequences similar to mouse mammary tumor virus in normal peripheral blood mononuclear cells. AIDS Res Hum Retroviruses (1996) 0.95
Prevalence and risk factors for HTLV-II infection in 913 injecting drug users in Stockholm, 1994. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 0.95
Selective antibody reactivity with peptides from human endogenous retroviruses and nonviral poly(amino acids) in patients with systemic lupus erythematosus. Arthritis Rheum (1996) 0.93
Human immunoglobulin class and subclass specificity of Fc receptors induced by herpes simplex virus type 1. J Virol (1984) 0.93
Classification of highly similar crude oils using data sets from comprehensive two-dimensional gas chromatography and multivariate techniques. J Chromatogr A (2005) 0.92
Identification of regions of HIV-1 p24 reactive with sera which give "indeterminate" results in electrophoretic immunoblots with the help of long synthetic peptides. AIDS Res Hum Retroviruses (1990) 0.91
Subtyping of herpes simplex virus. Acta Pathol Microbiol Scand B (1975) 0.91
Erythromycin and phenoxymethylpenicillin (penicillin V) in the treatment of respiratory tract infections as related to microbiological findings and serum C-reactive protein. Scand J Infect Dis (1991) 0.90
Detection of IgA antibodies against human papillomavirus in cervical secretions from patients with cervical intraepithelial neoplasia. Int J Cancer (1989) 0.90
CD4+ T-lymphocytopenia without HIV infection: increased prevalence among patients with primary Sjögren's syndrome. Clin Exp Rheumatol (1996) 0.88
Antibodies to human adult T cell leukaemia virus type I associated antigens in Swedish leukaemia patients and blood donors. Br J Haematol (1985) 0.87
Anti-STLV-IIImac reactivity in HIV seropositive individuals in Sweden. Lancet (1986) 0.87
Transcription of human endogenous retroviral sequences related to mouse mammary tumor virus in human breast and placenta: similar pattern in most malignant and nonmalignant breast tissues. AIDS Res Hum Retroviruses (1997) 0.85
Intrauterine death and infections during pregnancy. Int J Gynaecol Obstet (1995) 0.85
Two domains of the Borna disease virus p40 protein are required for interaction with the p23 protein. J Gen Virol (1998) 0.85
The rapid molecular subtyping and pathotyping of avian influenza viruses. J Virol Methods (2008) 0.84
Characterization of human MMTV-like (HML) elements similar to a sequence that was highly expressed in a human breast cancer: further definition of the HML-6 group. Virology (1999) 0.84
Glycosphingolipids of a green monkey kidney cell line (GMK AH-1). Evidence for a novel pentaglycosylceramide based on globotetraosylceramide. Biochim Biophys Acta (1982) 0.84
Differential pattern of oncogene and beta-actin expression in leukaemic cells from AML patients. Br J Haematol (1987) 0.84
Sequence evolution and cross-reactive antibody responses to hypervariable region 1 in acute hepatitis C virus infection. J Med Virol (2001) 0.83
Hospital-based study of sexually transmitted diseases at Murewa rural district hospital, Zimbabwe 1991-1992. Sex Transm Dis (1995) 0.83
Prevalence of blood-borne viral infections (cytomegalovirus, human herpesvirus-6, human herpesvirus-7, human herpesvirus-8, human T-cell lymphotropic virus-I/II, human retrovirus-5) among blood donors in Latvia. Ann Hematol (2001) 0.83
Telomeric location of retroviral oncogenes in humans. Hereditas (1991) 0.82
Recent enterovirus infection in type 1 diabetes: evidence with a novel IgM method. J Med Virol (2007) 0.82
Increased incidence of Kaposi sarcoma in Sweden before the AIDS epidemic. Eur J Cancer (1990) 0.82
Comparative studies on neutralisation of primary HIV-1 isolates by human sera and rabbit anti-V3 peptide sera. J Med Virol (1999) 0.81
Uptake of amplifiable fragments of retrotransposon DNA from the human alimentary tract. Mol Genet Genomics (2003) 0.81
Purification of herpes simplex virus. J Gen Virol (1974) 0.81
Coamplification and dispersion of adjacent human endogenous retroviral HERV-H and HERV-E elements; presence of spliced hybrid transcripts in normal leukocytes. Virology (1998) 0.81
Diagnostic value of abdominal drainage in individual risk assessment of pancreatic fistula following pancreaticoduodenectomy. Br J Surg (2013) 0.81
VIRUS--a laboratory information system for clinical virology. Methods Inf Med (1979) 0.80
Increased immunoglobulin G, but not M, binding to endogenous retroviral antigens in HIV-1 infected persons. J Med Virol (2000) 0.80
Comprehensive multi-dimensional chromatographic studies on the separation of saturated hydrocarbon ring structures in petrochemical samples. J Chromatogr A (2005) 0.80
Human retrovirus 5 sequences in peripheral blood cells of patients with B-cell non-Hodgkin's lymphoma. Int J Cancer (2000) 0.79
Hospital teaching status and volume related to mortality after pancreatic cancer surgery in a national cohort. Br J Surg (2015) 0.79
Functional aspects of odontocete head oil lipids with special reference to pilot whale head oil. Prog Chem Fats Other Lipids (1978) 0.78
Human retrovirus type 5 sequences in non-Hodgkin's lymphoma of T cell origin. AIDS Res Hum Retroviruses (2001) 0.78
Tropical spastic paraparesis associated with human T lymphotropic virus type I in an east African naturalised in Sweden. Br Med J (Clin Res Ed) (1987) 0.78
Characterization of herpes simplex virus type 1-induced Fc receptor in its interaction with rabbit immunoglobulin G (IgG). APMIS (1990) 0.78
Determination of rubella immunity by latex agglutination: its place in clinical routines. Scand J Infect Dis (1984) 0.78
Streptococcal protein G: a sensitive tool for detection of antibodies to human immunodeficiency virus proteins in Western blot analysis. Eur J Clin Microbiol (1987) 0.77
Comparison of comprehensive two-dimensional gas chromatography and gas chromatography--mass spectrometry for the characterization of complex hydrocarbon mixtures. J Chromatogr A (2000) 0.77
A novel serological technique: polymerase chain reaction enhanced immunoassay. Application to enterovirus IgM diagnosis. J Virol Methods (1999) 0.77
Identification of tryptic peptides unique to a 110,000-molecular weight polyprotein encoded by the T-8 isolate of murine leukemia virus. J Exp Med (1980) 0.77
Three-dimensional structure and antigenicity of transmembrane-protein peptides of the human immunodeficiency virus type 1. Effects of a neutralization-escape substitution. FEBS Lett (1993) 0.77
Serological evaluation of possible exposure to Ljungan virus and related parechovirus in autoimmune (type 1) diabetes in children. J Med Virol (2015) 0.76
Continuity and discontinuity in the anti-V3 IgG response of human immunodeficiency virus type 1-infected persons in a cross-sectional and longitudinal study using synthetic peptides. J Infect Dis (1995) 0.76
A cluster of continuous antigenic structures in the transmembrane protein of HIV-1: individual patterns of reactivity in human sera. Mol Immunol (1991) 0.76
HTLV-II among injecting drug users in Stockholm. Scand J Infect Dis (1994) 0.76
Structural prerequisites for intersubtype B and D antigenicity of the third variable envelope region (V3) of human immunodeficiency virus type 1. J Infect Dis (2000) 0.76
The humanized severe combined immunodeficient mouse as a model for primary human humoral response against HIV1 peptides. J Immunol Methods (1995) 0.76
Purification of virions and nucleocapsids of herpes simplex virus by means of metrizamide and sodium metrizoate gradients. Arch Virol (1976) 0.76
Assessing surgical quality: comparison of general and procedure-specific morbidity estimation models for the risk adjustment of pancreaticoduodenectomy outcomes. World J Surg (2014) 0.75
Seroepidemiology of human retroviruses in Ogun State of Nigeria. Scand J Infect Dis (1990) 0.75
Antibody prevalence against rubella among hospital personnel in Nigeria: implications for health care system and immunisation policy. Acta Trop (1990) 0.75
[Neurologic diseases associated with HTLV-I infections]. Lakartidningen (1989) 0.75